Literature DB >> 2060188

Aminoaciduria is an earlier index of renal tubular damage than conventional renal disease markers in the gentamicin-rat model of acute renal failure.

N A Macpherson1, M A Moscarello, D M Goldberg.   

Abstract

There are currently no reliable early markers of renal tubular damage. Since aminoaciduria is an accompanying feature of this condition, the usefulness of increased urinary amino acid excretion as a marker was investigated by inducing renal tubular necrosis in male Wistar rats by the administration of gentamicin (40 mg/kg/d) for 14 d. Plasma amino acids, urea, creatinine, protein and electrolytes, and urine amino acids, protein and N-acetylglucosaminidase (a lysosomal enzyme) were measured over a 20 d period. Amino acid excretion increased dramatically within 24 h of the initial dose for 14 of the 16 amino acids measured. The conventional renal disease markers listed above did not increase until after day 7. Glomerular damage caused by puromycin aminonucleoside did not induce aminoaciduria until marked proteinuria occurred (day 9), and even then amino acid excretion was much less than that caused by gentamicin. To distinguish whether the gentamicin-induced aminoaciduria was a consequence of tubular damage or inhibition of amino acid transport, isolated rat kidneys were perfused with a Krebs-Henseleit albumin buffer with and without gentamicin for 20 min, during which time urinary amino acids were quantitated. Gentamicin did not inhibit amino acid reabsorption. Thus, it appears that in the rat-gentamicin model of acute renal failure, urinary amino acids are early markers of renal tubular damage.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2060188

Source DB:  PubMed          Journal:  Clin Invest Med        ISSN: 0147-958X            Impact factor:   0.825


  5 in total

1.  Genome-Scale Model-Based Identification of Metabolite Indicators for Early Detection of Kidney Toxicity.

Authors:  Venkat R Pannala; Kalyan C Vinnakota; Shanea K Estes; Irina Trenary; Tracy P OˈBrien; Richard L Printz; Jason A Papin; Jaques Reifman; Tatsuya Oyama; Masakazu Shiota; Jamey D Young; Anders Wallqvist
Journal:  Toxicol Sci       Date:  2020-02-01       Impact factor: 4.849

2.  Glomerular and Tubular Renal Function after Repeated Once-Daily Tobramycin Courses in Cystic Fibrosis Patients.

Authors:  Florian Stehling; Rainer Büscher; Jörg Grosse-Onnebrink; Peter F Hoyer; Uwe Mellies
Journal:  Pulm Med       Date:  2017-01-04

3.  Urinary chemical fingerprint left behind by repeated NSAID administration: Discovery of putative biomarkers using artificial intelligence.

Authors:  Liam E Broughton-Neiswanger; Sol M Rivera-Velez; Martin A Suarez; Jennifer E Slovak; Pablo E Piñeyro; Julianne K Hwang; Nicolas F Villarino
Journal:  PLoS One       Date:  2020-02-13       Impact factor: 3.240

4.  Effects of intact and hydrolysed blue whiting proteins on blood pressure and markers of kidney function in obese Zucker fa/fa rats.

Authors:  Aslaug Drotningsvik; Åge Oterhals; Svein Are Mjøs; Linn Anja Vikøren; Ola Flesland; Oddrun Anita Gudbrandsen
Journal:  Eur J Nutr       Date:  2020-05-14       Impact factor: 5.614

5.  A Prospective Multicenter Trial to Evaluate Urinary Metabolomics for Non-invasive Detection of Renal Allograft Rejection (PARASOL): Study Protocol and Patient Recruitment.

Authors:  Miriam C Banas; Georg A Böhmig; Ondrej Viklicky; Lionel P Rostaing; Thomas Jouve; Lluis Guirado; Carme Facundo; Oriol Bestard; Hermann-Josef Gröne; Kazuhiro Kobayashi; Vladimir Hanzal; Franz Josef Putz; Daniel Zecher; Tobias Bergler; Sindy Neumann; Victoria Rothe; Amauri G Schwäble Santamaria; Eric Schiffer; Bernhard Banas
Journal:  Front Med (Lausanne)       Date:  2022-01-07
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.